Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.

Article  CAS  PubMed  Google Scholar 

Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115(2):168–86.

Article  CAS  PubMed  Google Scholar 

Harris EN, Gharavi AE, Hegde U, Derue G, Morgan SH, Englert H, Chan JK, Asherson RA, Hughes GR. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol. 1985;59(2):231–4.

Article  CAS  PubMed  Google Scholar 

Ruggeri M, Tosetto A, Palandri F, Polverelli N, Mazzucconi MG, Santoro C, Gaidano G, Lunghi M, Zaja F, De Stefano V, et al. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. J Thromb Haemost. 2014;12(8):1266–73.

Article  CAS  PubMed  Google Scholar 

Moulis G, Delavigne K, Huguet F, Fortenfant F, Beyne-Rauzy O, Adoue D. Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome. Rev Med Interne. 2011;32(12):724–9.

Article  CAS  PubMed  Google Scholar 

Cruz ACL, Colella MP, De Paula EV, Annichinno-Bizzachi J, Orsi FA. Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies. Eur J Intern Med. 2019;69:e6–7.

Article  PubMed  Google Scholar 

Yang YJ, Yun GW, Song IC, Baek SW, Lee KS, Ryu HW, Lee MW, Lee HJ, Yun HJ, Kim S, et al. Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia. Korean J Intern Med. 2011;26(4):449–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim KJ, Baek IW, Yoon CH, Kim WU, Cho CS. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies. Br J Haematol. 2013;161(5):706–14.

Article  CAS  PubMed  Google Scholar 

Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: “extra-criteria” manifestations and technical advances. Nat Rev Rheumatol. 2017;13(9):548–60.

Article  CAS  PubMed  Google Scholar 

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117(16):4190–207.

Article  CAS  PubMed  Google Scholar 

de Souza AW, Silva NP, de Carvalho JF, D’Almeida V, Noguti MA, Sato EI. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome. Lupus. 2007;16(10):782–7.

Article  PubMed  Google Scholar 

Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford). 2002;41(8):924–9.

Article  CAS  PubMed  Google Scholar 

Li R, Zhou YS, Jia Y, Li ZG. Analysis of risk factors in development of thrombosis in patients with antiphospholipid syndrome. Beijing Da Xue Xue Bao Yi Xue Ban. 2012;44(5):788–91.

CAS  PubMed  Google Scholar 

Girón-González JA, García del Río E, Rodríguez C, Rodríguez-Martorell J, Serrano A. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol. 2004;31(8):1560–7.

PubMed  Google Scholar 

Di Minno MN, Tremoli E, Coppola A, Lupoli R, Di Minno G. Homocysteine and arterial thrombosis: Challenge and opportunity. Thromb Haemost. 2010;103(5):942–61.

Article  PubMed  Google Scholar 

Kassis J, Neville C, Rauch J, Busque L, Chang ER, Joseph L, Le Comte M, Subang R, Fortin PR. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Thromb Haemost. 2004;92(6):1312–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lande MB, Thomas GA, Houghton DC. Membranous nephropathy associated with chronic immune thrombocytopenic purpura in childhood. Am J Kidney Dis. 2001;37(5):E40.

Article  CAS  PubMed  Google Scholar 

Nishizawa K, Yamashita T, Ogawa Y, Kobayashi H. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. CEN Case Rep. 2022;11(1):43–9.

Article  PubMed  Google Scholar 

Diz-Küçükkaya R, Hacihanefioğlu A, Yenerel M, Turgut M, Keskin H, Nalçaci M, Inanç M. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood. 2001;98(6):1760–4.

Article  PubMed  Google Scholar 

Frison L, Lombardi A, Caputo I, Semenzato G, Fabris F, Vianello F. Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study. Hematology. 2019;24(1):134–8.

Article  CAS  PubMed  Google Scholar 

Hernández-Molina G, Espericueta-Arriola G, Cabral AR. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol. 2013;31(3):382–8.

PubMed  Google Scholar 

Pierrot-DeseillignyDespujol C, Michel M, Khellaf M, Gouault M, Intrator L, Bierling P, Godeau B. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Br J Haematol. 2008;142(4):638–43.

Article  Google Scholar 

Bazzan M, Vaccarino A, Stella S, Sciascia S, Montaruli B, Bertero MT, Carignola R, Roccatello D. Patients with antiphospholipid syndrome and thrombotic recurrences: a real-world observation (the Piedmont cohort study). Lupus. 2016;25(5):479–85.

Article  CAS  PubMed  Google Scholar 

Cervera R, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Kiss E, Zeher MM, Tincani A, Kontopoulou-Griva I, Galeazzi M, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009;68(9):1428–32.

Article  CAS  PubMed  Google Scholar 

Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis. 2006;65(1):2–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Angelis V, Scurati S, Raschi E, Liutkus A, Belot A, Borghi MO, Meroni PL, Cimaz R. Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: report of a family with multiple anti-phospholipid positive members. J Autoimmun. 2009;32(1):60–3.

Article  PubMed  Google Scholar 

Chaturvedi S, Braunstein EM, Yuan X, Yu J, Alexander A, Chen H, Gavriilaki E, Alluri R, Streiff MB, Petri M, et al. Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS. Blood. 2020;135(4):239–51.

Article  PubMed  PubMed Central  Google Scholar 

Oztürk MA, Haznedaroğlu IC, Turgut M, Göker H. Current debates in antiphospholipid syndrome: the acquired antibody-mediated thrombophilia. Clin Appl Thromb Hemost. 2004;10(2):89–126.

Article  PubMed  Google Scholar 

Barbhaiya MZS, Ahmadzadeh Y, Costenbader K, Naden R, Erkan D. Development of new international classification criteria for antiphospholipid syndrome: phase III case collection results [abstract]. Arthritis Rheumatol. 2020;72 (suppl 10). https://acrabstracts.org/abstract/development-of-new-international-classification-criteria-for-antiphospholipidsyndrome-phase-iii-case-collection-results/